Sources | Names Used |
---|---|
CTRPv2 | 1S,3R-RSL-3 |
PharmacoGx | 1S,3R-RSL-3 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WDR61 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
mRNA | RAB38 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
mRNA | TDP2 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |
mRNA | NTN3 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
mRNA | SLC24A5 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
mRNA | RFK | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |
mRNA | NR0B1 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-06 |
mRNA | MEX3A | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-06 |
mRNA | RDH13 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
mRNA | CBR1 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |